Introduction: Breast cancer is the second most common cancer (10.4 % of all cancer incidence, both sexes counted) and the fifth most common cause of cancer death in the world. In 2005, breast cancer caused 502,000 deaths worldwide. Clinical evaluation could function as a valuable diagnostic tool. Clinical evaluation, however, is a simple method to detect cases as it is inexpensive and non-invasive and if found to be accurate, might be of great value.
Introduction:
A young woman presenting with a breast mass raises anxiety in both patient and family regarding the possibility of breast cancer. 1 Breast cancer is the second most common cancer (10.4 % of all cancer incidence, both sexes counted) and the fifth most common cause of cancer death in the world 2 .In 2005, breast cancer caused 502,000 deaths worldwide (7 % of cancer deaths; almost 1 % of all deaths 3 . Onefourth of women suffer from breast disease in their life time [2] [3] .
In Bangladesh Breast cancer is the second most common cancer among women and hospital data shows that it constitutes 13-17% of female cancer. 4 With the improvement in health care and increasing life expectancy, more and more women are being exposed to the risk of developing breast cancer. Breast lump is a very sensitive issue for the patient so a reliable, non-invasive and prompt diagnosis helps to lessen the associated anxiety and leads to early definitive treatment. Timely and accurate diagnosis of a breast lump with early intervention can bring down morbidity and mortality of malignant disease.
There are various modalities for the diagnosis of a breast lump such as mammography, ultrasonography, fine needle aspiration cytology (FNAC) but none of them are without impunity 5 .Early work by Magarey CJ et al. 6 was concerned with the development of a management plan for the outpatient diagnosis of breast symptoms and they concluded that in the majority of patients the presence or absence of malignancy can be established with a high degree of certainty before biopsy.
Clinical evaluation could function as a valuable diagnostic tool. Clinical evaluation, however, is a simple method to detect cases as it is inexpensive and non-invasive and if found to be accurate, might be of great value 7 . This would prove to be highly useful particularly in areas where funds and/or facilities may not be available for more sophisticated diagnostic methods. 8 The systematic use of the clinical examination criteria and the organizational platform would allow the clinicians to select malignant cases and plan inpatient/outpatient surgical treatment so as to avoid unnecessary admissions which will reduce hospital bed occupancy and expenditures incurred on the part of the patient.
However, Crone P et al. 9 found that while the diagnostic sensitivity of clinical examination was high, around 98 %, the specificity was rather low, averaging 48 %. In addition, the study disclosed a statistical possibility of overlooking a few malignant tumors when using these three procedures and they recommended excision of all palpable breast lumps.
There is an overall consensus that clinical breast examination (CBE) is useful in screening as well as in evaluation of a lump. About 3 % to 45 % of cancer diagnoses missed by mammography were reported as having been detected by CBE. Although the sensitivity of mammography is greater than that of CBE, there is a residual diagnostic value of CBE that favors its continued use in screening 10 .
The screening strategies of Western countries may not be suitable for Bangladesh because of the many differences between Asian and Caucasian women with respect to the physiology of mammary glands (breast size and density) and the clinical characteristics of breast cancers (peak age incidence) 9 . The strategies of wealthier countries, including developed Asian countries, may also be unsuitable for Bangladesh because of differences in health care resources. Thus, in current socio-economic condition of Bangladesh, a combination of CBE and SBE are being introduced at national level for breast cancer detection. If SBE and CBE suspect any growth or abnormalities, the woman should be referred. And could be performed during VIA or pap smear.
According to guidelines followed by American Cancer Society for breast cancer screening, woman of 20-39 years should have a clinical examination of breast (CBE) at least every three years and >40 years every year, performed by health care professional such as physician, nurse, physician assistant. CBE can be performed during pap smear 11 .
Aim: To evaluate patients referred to colposcopy clinic in BSMMU for breast symptoms by clinical breast examination (CBE).
Material and Method:
The study design was cross sectional study done in the colposcopy clinic in the department of Obstetrics and Gynaecology, under the 'Establishment of National centre for cervical and breast cancer screening and training at BSMMU' and 'Cervical and breast cancer screening and training in BSMMU' projects. The records of women who referred with a breast lump or referred for breast examination to Bangabandhu sheikh Mujib Medical University at colposcopy clinic , during the time period January 2009 to July 2013 were studied. Structured proformas were filled based on the information obtained from the individual patient. CBE was done and patients with breast lump and suspected malignancy were referred for imaging and FNAC for confirmation of diagnosis.
Study inclusion criteria were:
• Women (over the age of 21) referred for evaluation of a particular area of concern identified either by the woman herself or her primary physician and who were willing to participate in the screening were eligible for the study.
Study exclusion criteria were:
• patients with skin infection or inflammation in the breast,
• patients with prior breast cancer surgery or radiation,
• patients with scleroderma or other connective tissue
• Pregnant or lactating women
• Women with existing untreated malignancies, known metastatic disease
• Conditions that precluded fully informed consent Clinical Breast Examination: Clinical examination of the breast is a physical examination of breast, includes inspection and palpation of entire breast and regional lymphatic areas (including the lateral and medial borders and axilla) 12 .
Result:
A total of 752 patients fulfilled the inclusion criteria , demographic features are demonstrated in Table 1 . The mean age of the patients was 35.1±9.2 years, mean BMI was 22.5±2.1, about 30% subjects were postmenopausal and about 2% patients had history of breast cancer. Regarding the characteristics of the masses proved by cytology (FNAC), 109 were benign and 12 were malignant ( Table-IV) . 
Discussion:
The study design was cross sectional study done in the colposcopy clinic in the department of Obstetrics and Gynaecology, under the 'Establishment of National centre for cervical and breast cancer screening and training at BSMMU' and 'Cervical and breast cancer screening and training in BSMMU' projects.
The incidence of breast cancer increases with age doubling about every 10 years until menopause then the rate of increase slows dramatically 12-13. The agestandardized incidence of breast cancer for women in the USA is 124.0 per 100,000 women per year, with a median age at diagnosis in the United States of 61 years 14 . The mean age of the study subjects were 35±9.2years. About 30 % women were post menopausal.
Obesity is associated with twofold increase in risk of breast cancer in post menopausal age group whereas among premenopausal woman it is associated with a reduced incidence 13 . In the study the mean BMI was 22.5±2.1kg/m 3 .
Previous pregnancy may have been a contributing factor as described in previous reports 15 . Naliparity is associated with the life time incidence of breast cancer 16 . About 30% patients were naliparous in the study and 70 % patients were multiparous.
Upto 10% of breast cancers in western countries are due to genetic predisposition. Woman having history of benign breast disease and family history of breast cancer (first degree relatives) have a nine fold increased risk 16 . History of benign breast was found in 15% cases, but there was no patient with history of breast cancer.
Many studies have shown that oral contraceptive pill (OCP) use is associated with an increase in a young woman's risk of breast cancer [13] [14] [15] , although some studies suggest that the risk may be limited to recent use 17 . In the study the 45.5 % responders had a history of use of OCP.
Majority of women who come to the surgical OPD complain of either pain or lump in the breast or discharge from the nipple 4 , which is similar to our study. 40% patients complained of pain, 27 % of lump, 9% of nipple discharge, minority had other complains.
The breast pathology distribution observed in this study is in agreement with the data received from large scale screening and research trials 11, [18] [19] [20] . Out of 752
Subjects, 59% had no abnormality in CBE. 4% subject had lumpy fibrocystic breast, definite lump found in 121 cases and 6% had nipple discharge.
A review of 357 patients aged 25 years or less with a breast mass consistent with a fibroadenoma (clinically and on ultrasound), 0.8% were found to have a benign phyllodes tumor, and 0.3% had a breast carcinoma, the rest had benign disease 21 . Early presentation of breast carcinoma in a young woman may be very similar to that of fibroadenoma 22 . Among the patients who had definite lump, imaging and or cytology was done by the decision of the surgical colleagues. 12 patients proved to had malignancy and 109 patients had benign breast lump mainly fibroadenomas.
The present study include the use of CBE as a screening procedure as well as to identify the breast pathology of the patient who were referred for breast problem. However, the study also has several limitations. First, it was conducted at a single site, which might have resulted in selection bias. The quality of clinical breast examination needs to be increased by standardizing examination procedures. Careful, systematic palpation has been shown to increase detection of breast lumps. Patient position, palpation of breast boundaries, and examination pattern and technique are important variables in CBE 23 . Largesample and multicentre clinical studies with trained professional in CBE could be done.
Conclusion:
CBE is an important screening procedure to identify breast pathology. Out of 752 patients breast pathology were identified in about 41% of patients and 10% breast lumps were malignant. So CBE should be done every three yearly in <40 and yearly in above 40 years women.
